Adhera Therapeutics, Inc. (ATRX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.41 Million | -665 Thousand | -588 Thousand | -8.73 Million | -9.61 Million | -1.26 Million |
| Net Income | -2.11 Million | -6.35 Million | -3.76 Million | -11.97 Million | -16.75 Million | -6.21 Million |
| Depreciation & Amortization | 1.8 Million | 398 Thousand | 400 Thousand | 82 Thousand | 332.98 Thousand | 450.9 Thousand |
| Deferred income taxes | - | - | -400 Thousand | 1.23 Million | 6.24 Million | - |
| Stock-based compensation | - | - | 8000.00 | 765 Thousand | 1.44 Million | 424.78 Thousand |
| Change in working capital | 203 Thousand | 9000.00 | 1.39 Million | 480 Thousand | -1.47 Million | 2.62 Million |
| Other non-cash items | -1.31 Million | 5.27 Million | 1.77 Million | 679 Thousand | 599.9 Thousand | 1.45 Million |
| Investing Cash Flow | - | - | - | - | -74.36 Thousand | -375 Thousand |
| Investments in PPE | - | - | - | - | -74.36 Thousand | -375 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | -74.36 Thousand | -375.00 |
| Financing Cash Flow | 1.37 Million | 739 Thousand | 539 Thousand | 4.87 Million | 13.49 Million | 1.63 Million |
| Debt repayment | -581 Thousand | -739 Thousand | -539 Thousand | -1.5 Million | -143.83 Thousand | -24 Thousand |
| Dividends payments | -620 Thousand | -2.05 Million | -1.54 Million | -1.5 Million | -1.06 Million | - |
| Common Stock Repurchased | -2000.00 | -739 Thousand | -539 Thousand | -100 Thousand | -250 Thousand | - |
| Common Stock Issuance | 5.05 Million | 116 Thousand | 23 Thousand | 4000.00 | 13.89 Million | 250 Thousand |
| Other Financing Activities | -2.48 Million | 4.15 Million | 3.13 Million | 7.97 Million | 1.06 Million | 1.41 Million |
| Accounts receivables | - | 120 Thousand | - | 16 Thousand | -116.36 Thousand | - |
| Accounts payables | 68 Thousand | 94 Thousand | 854 Thousand | 1.13 Million | -703.15 Thousand | 425.33 Thousand |
| Inventory | - | -120 Thousand | - | -240 Thousand | -204.36 Thousand | - |
| Other working capital | 135 Thousand | -85 Thousand | 542 Thousand | -429 Thousand | -452.81 Thousand | 2.2 Million |
| Cash at beginning of period | 76 Thousand | 1000.00 | 50 Thousand | 3.91 Million | 106.37 Thousand | 105.34 Thousand |
| Cash at end of period | 32 Thousand | 75 Thousand | 1000.00 | 50 Thousand | 3.91 Million | 106.37 Thousand |
| Capital Expenditure | - | - | - | - | -74.36 Thousand | -375 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -44 Thousand | 74 Thousand | -49 Thousand | -3.86 Million | 3.81 Million | 1031.00 |
| Free Cash Flow | -1.41 Million | -665 Thousand | -588 Thousand | -8.73 Million | -9.68 Million | -1.63 Million |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.53 Million | 271 Thousand | -886 Thousand | -335 Thousand | -2.11 Million | -1.8 Million |
| Depreciation & Amortization | 245.82 Thousand | - | 608 Thousand | 1.03 Million | 1.8 Million | 777 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.29 Million | -21 Thousand | 43 Thousand | 208 Thousand | 203 Thousand | -24 Thousand |
| Other non-cash items | 2.21 Million | -566 Thousand | -75 Thousand | -1.05 Million | -1.31 Million | 479 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 3782.00 | 305 Thousand | 347 Thousand | 52 Thousand | 1.37 Million | -144 Thousand |
| Debt repayment | -4182.00 | -305 Thousand | -95 Thousand | -30 Thousand | -581 Thousand | -144 Thousand |
| Dividends payments | - | - | -26 Thousand | -574 Thousand | -620 Thousand | - |
| Common Stock Repurchased | - | - | - | -2000.00 | -2000.00 | - |
| Common Stock Issuance | - | - | - | 5.05 Million | 5.05 Million | - |
| Other Financing Activities | 7964.00 | 610 Thousand | 468 Thousand | -4.36 Million | -2.48 Million | 8000.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 80.26 Thousand | -97 Thousand | 8000.00 | 106 Thousand | 68 Thousand | -68 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.21 Million | 76 Thousand | -8000.00 | 102 Thousand | 135 Thousand | 44 Thousand |
| Cash at beginning of period | 58 Thousand | 69 Thousand | 32 Thousand | 133 Thousand | 76 Thousand | 849 Thousand |
| Cash at end of period | 32.38 Thousand | 58 Thousand | 69 Thousand | 32 Thousand | 32 Thousand | 133 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -25.61 Thousand | -11 Thousand | 37 Thousand | -101 Thousand | -44 Thousand | -716 Thousand |
| Free Cash Flow | -29.15 Thousand | -316 Thousand | -310 Thousand | -153 Thousand | -1.41 Million | -572 Thousand |
ARKO
0703
CBDD
8923
EXPO
2796